Je. Bueld et al., EFFECTS OF PROPIONIC-ACID AND PRAVASTATIN ON HMG-COA REDUCTASE-ACTIVITY IN RELATION TO FORESTOMACH LESIONS IN THE RAT, Pharmacology & toxicology, 78(4), 1996, pp. 229-234
Administration of 4% propionic acid in powdered diet to rats for 12 we
eks induces severe hyperplastic lesions in the forestomach mucosa. The
mechanisms underlying this damage are not yet clear. Several lipophil
ic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor
s such as lovastatin and simvastatin produce forestomach lesions simil
ar to propionic acid after oral administration and the degree of alter
ations is correlated with their in vitro inhibitory potency (Kloss et
al. 1998). Therefore it is possible, that sustained inhibition of HMG-
CoA reductase and induction of hyperplasias may be somehow connected.
For that reason we investigated, whether or not propionic acid has any
influence on HMG-CoA reductase activity in vitro and in vivo, because
propionic acid has been suggested to suppress liver cholesterol synth
esis, and also whether or not pravastatin, a more polar HMG-CoA reduct
ase inhibitor than lovastatin displays similar effects on forestomach
mucosa. In untreated forestomach microsomes in vitro, propionic acid a
t a concentration of 51 mM (pH 5.7) inhibited HMG-CoA reductase activi
ty by 51+/-10%, but at pH 7.2 no inhibition of the enzyme could be det
ected. Furthermore 4% propionic acid-treatment did not lower serum cho
lesterol. In contrast to lovastatin (Kloss et al. 1991), oral administ
ration of pravastatin (up to 25% in the diet) did not produce any fore
stomach lesions in the rat. On the other hand, pretreatment with prava
statin revealed that HMG-CoA reductase activity in microsomes exceeded
the activity of control forestomach and liver microsomes by 4.9 fold
and 6.7 fold respectively, whereas no induction of this enzyme (neithe
r liver nor forestomach) could be observed by pretreatment with 4% pro
pionic acid for 12 weeks. Despite increased hepatic HMG-CoA reductase
activity, pravastatin-treatment significantly lowered serum cholestero
l levels of rats. These results show that sustained inhibition of HMG-
CoA reductase activity in forestomach microsomes is not strongly conne
cted with hyperplasia development.